Sarah Ford | November 20, 2014
Drug Restores Memory Function in Alzheimer’s Model
Building on earlier work funded by BrightFocus, researchers have discovered a promising new drug compound that reverses some
Alzheimer’s effects on memory in mice.
Four years ago, a research team led by BrightFocus grantee and Nobel Laureate Dr. Paul Greengard established the connection between increased striatal-enriched tyrosine phosphatase (STEP) levels and Alzheimer’s changes in mice, and showed that removing STEP had the effect of restoring synaptic connections.
Since their discovery of STEP, this research team has been searching for a drug that would block its damaging effects on brain synapses. They focused their efforts on finding a STEP inhibitor, studying thousands of small molecules in their quest.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Women’s Health Month
May is Women’s Health Month, a time when we focus on the importance of taking care of ourselves and our health. This month is an…
Read Article
Military Spouse Appreciation Day
May 10 marks the celebration of Military Spouse Appreciation Day, a time to honor and recognize the immense contributions made by military spouses in supporting…
Read Article
Melanoma and Skin Cancer Awareness Month
Melanoma is an aggressive form of skin cancer. In addition to the skin, melanoma may also occur in mucous membranes – thin, moist layers of tissue that cover surfaces…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
